Devices








BFlux_Cleared_FDA_Image Dec 2017

Biotricity’s Bioflux Achieves FDA 510(k) Clearance

  Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has received its 510(k) clearance for its Bioflux device with the U.S. Food and Drug Administration (FDA). This…